BioCentury
ARTICLE | Company News

CMC Biologics A/S, ExpreS2ion, University of Copenhagen deal

December 16, 2013 8:00 AM UTC

CMC said earlier this year it partnered with the university and will provide process development expertise and cGMP clinical production of the university's variant surface antigen 2 chondroitin sulph...